Biochemical Journal · 1980 · 27 citations · 22 references
MedicineEndocrinologyPharmacologyCell SignalingEndocrine OncologySignal TransductionNuclear ReceptorsThyroid CancerThyroid EndocrinologyCalcitonin InteractionCalcitonin PharmacologyDisplacementMedullary Thyroid Carcinoma PathologyReceptor-ligand Binding
The human epidermoid bronchial carcinoma (BEN) cell line has been shown to have specific membrane binding sites for calcitonin and to secrete high-molecular-weight forms (ranging from 40000 to 10000) of immunoreactive calcitonin. Synthetic salmon and human calcitonins and a thyroid extract of porcine calcitonin have been shown to displace 125I-labelled salmon calcitonin from the receptors in a dose-related fashion. The binding to these receptors of calcitonins derived from the BEN cell line and a medullary thyroid carcinoma with molecular weights ranging from 28000 to 3500 (both separated by gel-filtration chromatography) has been investigated. Neither major peaks of BEN-cell-line calcitonin showed receptor binding activity. Only one form of medullary thyroid carcinoma calcitonin, that which co-eluted with synthetic calcitonin monomer on gel-filtration chromatography, caused any significant displacement of labelled hormone from the receptors.
22
PLASMA-IMMUNOREACTIVE-CALCITONIN IN PATIENTS WITH NON-THYROID TUMOURS
R. Charles Coombes, P. B. Greenberg, Carmel J. Hillyard et al. · The Lancet · 1974 · 183 citations
Identification and processing of proglucagon in pancreatic islets
Christoph Patzelt, Howard S. Tager, Raymond J. Carroll et al. · Nature · 1979 · 146 citations
Ectopic Secretion of Calcitonin by Oat-Cell Carcinoma
Omega L. Silva, Kenneth L. Becker, Aron Primack et al. · New England Journal of Medicine · 1974 · 125 citations
Medicine, Endocrinology, Oncology +11